Suchergebnisse

The genetic information that is available to insurance companies has often been regulated to avoid certain ethical difficulties. But regulation may not be the solution, argue the authors, and suggest instead the resurrection of collectively funded public insurances. This will interest academic researchers and professionals involved with genetics and insurance